These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 37741760)

  • 1. Statistical considerations on real time and extended controlled temperature conditions (ECTC) stability data analysis of vaccines.
    Kim DR; You YA; Ahn HS; Park EL; Lim JK; Song KR; Chon Y; Lynch J
    Vaccine; 2023 Oct; 41(42):6206-6214. PubMed ID: 37741760
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of the stability of measles vaccine out of the cold chain under extended controlled temperature conditions.
    Juan-Giner A; Alsalhani A; Panunzi I; Lambert V; Van Herp M; Gairola S
    Vaccine; 2020 Mar; 38(11):2473-2477. PubMed ID: 32046890
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk factors for improper vaccine storage and handling in private provider offices.
    Bell KN; Hogue CJ; Manning C; Kendal AP
    Pediatrics; 2001 Jun; 107(6):E100. PubMed ID: 11389298
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Can thermostable vaccines help address cold-chain challenges? Results from stakeholder interviews in six low- and middle-income countries.
    Kristensen DD; Lorenson T; Bartholomew K; Villadiego S
    Vaccine; 2016 Feb; 34(7):899-904. PubMed ID: 26778422
    [TBL] [Abstract][Full Text] [Related]  

  • 5. How the use of vaccines outside the cold chain or in controlled temperature chain contributes to improving immunization coverage in low- and middle-income countries (LMICs): A scoping review of the literature.
    Dadari IK; Zgibor JC
    J Glob Health; 2021 Jan; 11():04004. PubMed ID: 33692889
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A universal tool for stability predictions of biotherapeutics, vaccines and in vitro diagnostic products.
    Huelsmeyer M; Kuzman D; Bončina M; Martinez J; Steinbrugger C; Weusten J; Calero-Rubio C; Roche W; Niederhaus B; VanHaelst Y; Hrynyk M; Ballesta P; Achard H; Augusto S; Guillois M; Pszczolinski C; Gerasimov M; Neyra C; Ponduri D; Ramesh S; Clénet D
    Sci Rep; 2023 Jun; 13(1):10077. PubMed ID: 37344503
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An evaluation of the cold chain technology in South-East, Nigeria using Immunogenicity study on the measles vaccines.
    Oli AN; Agu RU; Ihekwereme CP; Esimone CO
    Pan Afr Med J; 2017; 27(Suppl 3):28. PubMed ID: 29296163
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evidence of Extended Thermo-Stability of Typhoid Polysaccharide Conjugate Vaccines.
    Gao F; Lockyer K; Logan A; Davis S; Bolgiano B; Rijpkema S; Singh G; Prasad SD; Dondapati SP; Sounkhla GS
    Microorganisms; 2021 Aug; 9(8):. PubMed ID: 34442786
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Demonstration of real-time and accelerated stability of hepatitis E vaccine with a combination of different physicochemical and immunochemical methods.
    Yin X; Wang X; Zhang Z; Li Y; Lin Z; Pan H; Gu Y; Li S; Zhang J; Xia N; Zhao Q
    J Pharm Biomed Anal; 2020 Jan; 177():112880. PubMed ID: 31546137
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Accurate prediction of vaccine stability under real storage conditions and during temperature excursions.
    Clénet D
    Eur J Pharm Biopharm; 2018 Apr; 125():76-84. PubMed ID: 29341899
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A cluster randomized non-inferiority field trial on the immunogenicity and safety of tetanus toxoid vaccine kept in controlled temperature chain compared to cold chain.
    Juan-Giner A; Domicent C; Langendorf C; Roper MH; Baoundoh P; Fermon F; Gakima P; Zipursky S; Tamadji M; Grais RF
    Vaccine; 2014 Oct; 32(47):6220-6. PubMed ID: 25261378
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thermal stability and storage of human insulin.
    Richter B; Bongaerts B; Metzendorf MI
    Cochrane Database Syst Rev; 2023 Nov; 11(11):CD015385. PubMed ID: 37930742
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stability of heat stable, live attenuated Rotavirus vaccine (ROTASIIL®).
    Naik SP; Zade JK; Sabale RN; Pisal SS; Menon R; Bankar SG; Gairola S; Dhere RM
    Vaccine; 2017 May; 35(22):2962-2969. PubMed ID: 28434688
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effectiveness of a web-based education program to improve vaccine storage conditions in primary care (Keep Cool): study protocol for a randomized controlled trial.
    Thielmann A; Viehmann A; Weltermann BM
    Trials; 2015 Jul; 16():301. PubMed ID: 26169675
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antivenoms, hepatitis B vaccine and oral polio vaccine can be considered for storage and handling outside the cold chain following the innovative 'controlled temperature chain' approach.
    Mohamed SH; Hady OA; Kashef MT; Zedan H
    Biologicals; 2022 Jul; 78():27-35. PubMed ID: 35803876
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influenza virus vaccine live intranasal--MedImmune vaccines: CAIV-T, influenza vaccine live intranasal.
    Drugs R D; 2003; 4(5):312-9. PubMed ID: 12952502
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stability of lyophilized Meningococcal A conjugate vaccine, (MenAfriVac™) at elevated temperatures to support controlled temperature chain (CTC) claim.
    Gairola S; Bonde P; Sharma P; Kale S; Goel S; Jadhav S
    Biologicals; 2023 Aug; 83():101698. PubMed ID: 37562242
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cold chain in a hot climate.
    Guthridge SL; Miller NC
    Aust N Z J Public Health; 1996 Dec; 20(6):657-60. PubMed ID: 9117976
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Temperature stability of oxytocin ampoules labelled for storage at 2°C-8°C and below 25°C: an observational assessment under controlled accelerated and temperature cycling conditions.
    Nguyen TH; Lambert P; Minhas RS; McEvoy C; Deadman K; Wright P; Prankerd RJ; Mogatle S; McIntosh MP
    BMJ Open; 2019 Jul; 9(7):e029083. PubMed ID: 31350247
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Benefits of using vaccines out of the cold chain: delivering meningitis A vaccine in a controlled temperature chain during the mass immunization campaign in Benin.
    Zipursky S; Djingarey MH; Lodjo JC; Olodo L; Tiendrebeogo S; Ronveaux O
    Vaccine; 2014 Mar; 32(13):1431-5. PubMed ID: 24559895
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.